Understanding cancer genomics in East Africa
Cancer Genomics and Genomic Data Science for East Africa
['FUNDING_OTHER'] · FRED HUTCHINSON CANCER CENTER · NIH-10871885
This study is working to improve cancer care in East Africa by training local scientists and building resources to better understand African tumors, so patients can receive more personalized and effective treatments that consider their unique genetic backgrounds.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | FRED HUTCHINSON CANCER CENTER (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-10871885 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing cancer genomics and data science capabilities in East Africa. It aims to address the underrepresentation of African tumors and scientists in global cancer genomics initiatives. By building infrastructure and training professionals in genomic data generation and analysis, the project seeks to improve cancer prevention, diagnosis, and treatment in the region. Patients can expect advancements in personalized cancer care that reflect the genetic diversity of African populations.
Who could benefit from this research
Good fit: Ideal candidates for this research include African patients diagnosed with various types of cancer who are interested in contributing to genomic studies.
Not a fit: Patients outside of Africa or those with cancers not represented in the genomic analyses may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments tailored to the genetic profiles of African patients.
How similar studies have performed: Other research initiatives have successfully improved cancer treatment outcomes by incorporating diverse genomic data, indicating potential for success in this novel approach.
Where this research is happening
SEATTLE, UNITED STATES
- FRED HUTCHINSON CANCER CENTER — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WARREN, EDUS HOUSTON — FRED HUTCHINSON CANCER CENTER
- Study coordinator: WARREN, EDUS HOUSTON
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Advanced Cancer, Cancer Patient, Cancer Treatment, Cancers, Communicable Diseases